|
CSR160805-20747
| S84989-1g | 1g | MedMol |
|
Cinaciguat
| S84948-5mg | 5mg | MedMol |
|
Cinaciguat
| S84948-10mg | 10mg | MedMol |
|
Cis-Thiothixene
| S84965-5mg | 5mg | MedMol |
|
Cis-Thiothixene
| S84965-10mg | 10mg | MedMol |
|
Cis-Thiothixene
| S84965-25mg | 25mg | MedMol |
|
Cytosporone B
| S84911-5mg | 5mg | MedMol |
|
Cytosporone B
| S84911-25mg | 25mg | MedMol |
|
Cytosporone B
| S84911-100mg | 100mg | MedMol |
|
CL 82198
| S84860-5mg | 5mg | MedMol |
|
CL 82198
| S84860-10mg | 10mg | MedMol |
|
CL 82198
| S84860-25mg | 25mg | MedMol |
|
CL 82198
| S84860-50mg | 50mg | MedMol |
|
CB 300919
| S84795-5mg | 5mg | MedMol |
|
CB 300919
| S84795-10mg | 10mg | MedMol |
|
CY2
| S84689-5mg | 5mg | MedMol |
|
CPA inhibitor
| S84507-5mg | 5mg | MedMol |
|
CPA inhibitor
| S84507-10mg | 10mg | MedMol |
|
Collagen proline hydroxylase inhibitor
| S84513-5mg | 5mg | MedMol |
|
Cinacalcet
| S84527-10mg | 10mg | MedMol |
|
Cinacalcet
| S84527-50mg | 50mg | MedMol |
|
CX 546
| S84440-10mg | 10mg | MedMol |
|
CX 546
| S84440-50mg | 50mg | MedMol |
|
Cyclohexanecarboxylic acid, 4-[bis(phenylmethyl)amino]-, ethyl ester, trans-
| S84462-100mg | 100mg | MedMol |
|
Cyclohexanecarboxylic acid, 4-[bis(phenylmethyl)amino]-, ethyl ester, trans-
| S84462-250mg | 250mg | MedMol |
|
Cyclohexanecarboxylic acid, 4-[bis(phenylmethyl)amino]-, ethyl ester, trans-
| S84462-500mg | 500mg | MedMol |
|
Camtobell hydrochloride
| S84423-5mg | 5mg | MedMol |
|
Camtobell hydrochloride
| S84423-50mg | 50mg | MedMol |
|
C75
| S84450-5mg | 5mg | MedMol |
|
Camtobell hydrochloride
| S84423-10mg | 10mg | MedMol |
|
Camtobell hydrochloride
| S84423-25mg | 25mg | MedMol |
|
Carbamic acid, [(1S)-2-[[(7S)-6,7-dihydro-5-methyl-6-oxo-5H-dibenz[b,d]azepin-7-yl]amino]-1-methyl-2-oxoethyl]-, 1,1-dimethyleth
| S84374-100mg | 100mg | MedMol |
|
CB30865
| S84338-5mg | 5mg | MedMol |
|
CB30865
| S84338-10mg | 10mg | MedMol |
|
Cyclopropanecarboxylic acid, 2-[(4R)-1-[(4-methoxyphenyl)methyl]-2,5-dioxo-4-(9H-xanthen-9-ylmethyl)-4-imidazolidinyl]-, 4-metho
| S84288-1g | 1g | MedMol |
|
Cyclopropanecarboxylic acid, 2-[(4R)-1-[(4-methoxyphenyl)methyl]-2,5-dioxo-4-(9H-xanthen-9-ylmethyl)-4-imidazolidinyl]-, (4-meth
| S84301-100mg | 100mg | MedMol |
|
Carbamic acid, N-[(1S)-5-[[(1,1-dimethylethoxy)carbonyl]amino]-1-[[4-(4-pyridinyl)-1-piperazinyl]carbonyl]pentyl]-, phenylmethyl
| S84318-100mg | 100mg | MedMol |
|
Carbamic acid, N-[(5S)-5-amino-6-oxo-6-[4-(4-pyridinyl)-1-piperazinyl]hexyl]-, 1,1-dimethylethyl ester
| S84319-1g | 1g | MedMol |
|
Carbamic acid, [5-[[2-amino-3-(3,5-dibromo-4-hydroxyphenyl)-1-oxopropyl]amino]-6-oxo-6-[4-(4-pyridinyl)-1-piperazinyl]hexyl]-, 1
| S84322-100mg | 100mg | MedMol |
|
Carbamic acid, [5-[[2-amino-3-(3,5-dibromo-4-hydroxyphenyl)-1-oxopropyl]amino]-6-oxo-6-[4-(4-pyridinyl)-1-piperazinyl]hexyl]-, 1
| S84322-250mg | 250mg | MedMol |
|
Carbamic acid, [5-[[2-amino-3-(3,5-dibromo-4-hydroxyphenyl)-1-oxopropyl]amino]-6-oxo-6-[4-(4-pyridinyl)-1-piperazinyl]hexyl]-, 1
| S84322-500mg | 500mg | MedMol |
|
CDD3506
| S84247-5mg | 5mg | MedMol |
|
CDD3506
| S84247-10mg | 10mg | MedMol |
|
Carbamic acid, [(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]-, phenylmethyl ester oxalate
| S84264-1g | 1g | MedMol |
|
CVT-313
| S84270-5mg | 5mg | MedMol |
|
CVT-313
| S84270-10mg | 10mg | MedMol |
|
CVT-313
| S84270-50mg | 50mg | MedMol |
|
Cortexolone 17 alpha-propionate
| S84223-5mg | 5mg | MedMol |
|
Cortexolone 17 alpha-propionate
| S84223-10mg | 10mg | MedMol |
|
Cortexolone 17 alpha-propionate
| S84223-50mg | 50mg | MedMol |
